3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Prostatic Neoplasms
3
Pancreatic Neoplasms
2
Neoplasms
2
Gastrointestinal Neoplasms
2
Carcinoma, Non-Small-Cell Lung
2
Small Cell Lung Carcinoma
1
Sarcoma
1
Recurrence
1
Pancreatic Cancer Resectable
1
Lung Neoplasms
1
Leukemia, Myeloid, Acute
1
Leukemia, Lymphocytic, Chronic, B-Cell
1
Leukemia
1
Estrogen Receptor Positive Breast Cancer
1
Colorectal Neoplasms
1
Colonic Neoplasms
1
Cholangiocarcinoma
1
Carcinoma, Renal Cell
1
COVID-19
1
Breast Neoplasms, Male
1
Breast Neoplasms
1
Bone Metastases
1
Biliary Tract Neoplasms
1
Bile Duct Neoplasms
1
Adenocarcinoma of Lung
1
Interventions
avelumab
1
Hydroxychloroquine
1
Gemcitabine
1
130-nm albumin-bound paclitaxel
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Terminated
×
Pancreatic Cancer Resectable
×
Hydroxychloroquine
×
Clear all
NCT03344172
2020-05-14
17-134
University of Pittsburgh
Phase 2
Terminated
32 enrolled
14 charts